Cytotoxic T lymphocytes, chemokines and antiviral immunity.
about
Expression profile of immune response genes in patients with Severe Acute Respiratory SyndromeHepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impactAlpha E: no more rejection?Differences in Hepatitis C Virus (HCV)-Specific CD8 T-Cell Phenotype during Pegylated Alpha Interferon and Ribavirin Treatment Are Related to Response to Antiviral Therapy in Patients Chronically Infected with HCVRole of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infectionDiverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophilsInfergen Stimulated Macrophages Restrict Mycobacterium tuberculosis Growth by Autophagy and Release of Nitric Oxide.Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injuryImmunopathogenesis of hepatitis C virus in the immunosuppressed host.Monoclonal TCR-redirected tumor cell killing.Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vici!!The role of serum antibodies in the protection against rotavirus disease: an overview.Migration and differentiation of CD8+ T cells.Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function.Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitopeInhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitisImmunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responsesMacrophage-tropic HIV induces and exploits dendritic cell chemotaxisBlocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.Functional signatures of protective antiviral T-cell immunity in human virus infections.Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategiesCodelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1.Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example.Lymphocytic choriomeningitis virus-induced central nervous system disease: a model for studying the role of chemokines in regulating the acute antiviral CD8+ T-cell response in an immune-privileged organHuman leucocyte antigen class I-redirected anti-tumour CD4+ T cells require a higher T cell receptor binding affinity for optimal activity than CD8+ T cells.CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functions.Recognition of nonpeptide antigens by human V gamma 9V delta 2 T cells requires contact with cells of human origin.Potent induction of IFN-γ production from cord blood NK cells by the stimulation with single-stranded RNA.Type I IFN-beta gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis.Evaluation of the natural immunity in pups inoculated with a modified-live canine parvovirus type 2b (CPV-2b) strain.
P2860
Q21263138-EAB08B9D-C9A3-4409-8162-0E03A36268B1Q22299128-017A67FC-10E1-4ED0-AAAF-5248BCECB993Q24673125-D4818D7D-62DA-412D-8F18-7B8433F4843AQ27486579-801355A6-CF60-442E-A108-86C675E1E604Q27490393-D568C92E-1C87-4D3F-A452-E78890E12F34Q28205971-C8142938-2A1D-4B6E-964F-B37770BF078BQ30832644-E321390A-FDC1-4B29-9CFE-DDC5297E7C4FQ33195470-48553D29-6F7D-4EDA-8046-C1DEBDA3C19CQ34148593-8C062F0E-E560-493E-AC67-4C5DDC880EECQ34273053-9C1BC35F-221F-4205-8F16-D4933D47CDCAQ34311546-8965C1BB-17B9-4455-A79B-21F176431E8BQ34618449-4D745A71-F4AE-452A-93CB-DB6F9EF83FE6Q34862369-C83D39A3-FB0B-456E-9386-EA85E7114F8AQ35209368-3DF1DBD8-6DF0-46FF-8100-9F048340DB74Q35274855-8192C0E6-78C2-4576-BFB5-EFCEE9F35506Q35848218-54B27983-0A91-42A4-BCBC-F3A5DE3A3CBAQ36229406-2EB56B94-B67D-4681-BA15-AF2DABFD09FDQ36368696-425432BF-4233-4E6D-834F-1C213EA3E7A1Q36369807-617396D3-9E4C-4B0A-AB05-140780310515Q36402998-7E55690F-E2C1-46D6-8B1D-3592B48DB8F3Q36529008-1E92E700-5C5D-44B6-92A4-095F081F6DAEQ36561567-49ED7EE3-73F1-4032-8F7C-44AF46EF09F0Q37059943-FC23D805-397C-4037-AC3B-77400C99400CQ37118101-6D638498-798D-4795-9C10-B78B810B15E9Q37267001-960F6229-4400-4349-9A7D-F4DEED2DCFD4Q38763198-60BB29A8-3A1E-4131-9FA6-8B23C8403E38Q40152588-F66ACEB6-D1CB-469A-8155-E5E6396E4444Q44898932-FFF647C8-DCAA-4B1D-8B98-880C9B199138Q44993630-51AFA61F-AB7D-44AA-933C-EDD3BF5F9663Q45874274-7FB766D4-9555-4411-A6AE-1E6E970961F5Q50119809-08037DE0-075F-4460-913F-86DD56EE8E67
P2860
Cytotoxic T lymphocytes, chemokines and antiviral immunity.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Cytotoxic T lymphocytes, chemokines and antiviral immunity.
@ast
Cytotoxic T lymphocytes, chemokines and antiviral immunity.
@en
type
label
Cytotoxic T lymphocytes, chemokines and antiviral immunity.
@ast
Cytotoxic T lymphocytes, chemokines and antiviral immunity.
@en
prefLabel
Cytotoxic T lymphocytes, chemokines and antiviral immunity.
@ast
Cytotoxic T lymphocytes, chemokines and antiviral immunity.
@en
P2093
P1433
P1476
Cytotoxic T lymphocytes, chemokines and antiviral immunity.
@en
P2093
P304
P356
10.1016/S0167-5699(99)01447-4
P577
1999-05-01T00:00:00Z